Login / Signup

Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients.

Sarah BesoraCristina SantosCristina IzquierdoMaria Mercedes Martinez-VillacampaJordi BrunaRoser Velasco
Published in: Journal of cancer research and clinical oncology (2018)
Retreatment with OXA in CRC patients is a feasible option even in patients who previously developed moderate or severe OIN. One-third of patients' OIN was worsened by retreatment. Neurological monitoring should be considered.
Keyphrases